Running, esophageal acid reflux, and atrial fibrillation: a chain of events linked by evidence from separate medical literatures.

Using a previously described approach to generating novel medical hypotheses, this paper shows how two separate medical literatures taken together can suggest new information not apparent in either literature alone. Many studies have demonstrated that aerobic exercise in healthy people can induce esophageal acidic reflux that increases with the duration and intensity of exercise. Separately, independently of exercise, it has been shown that, in patients with gastroesophageal reflux, esophageal acid exposure can lead to atrial fibrillation (AF) and to other heart dysrhythmias. The two arguments together suggest that a regimen of excessive exercise may be conducive to AF mediated by acid reflux, an implicit, but unpublished, hypothesis. Proton pump inhibitors are widely used to treat gastroesophageal reflux. Remarkably, several small clinical trials of these drugs have been shown also to reduce symptoms and frequency of AF episodes in patients with comorbid acid reflux. Plausible mechanisms have been suggested. These small-scale tests in a highly restricted population may be of particular interest in the light of a possible exercise-reflux-AF causal chain of events in a broader population of athletes. Because the minimum degree of esophageal acidity exposure required to induce AF is unknown, further tests of proton pump inhibitors for that purpose are therefore merited without regard to any known prior reflux in a population of runners with lone AF. The prospect of reducing AF burden with a relatively benign agent is attractive in view of the limited options for effective treatment otherwise available. The study of arrhythmia and esophageal reflux in athletes may offer insights on the origin and natural history of lone atrial fibrillation.

[1]  P. Usai,et al.  Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias , 2006, Alimentary pharmacology & therapeutics.

[2]  M. Bemben,et al.  Esophageal reflux in conditioned runners, cyclists, and weightlifters. , 2003, Medicine and science in sports and exercise.

[3]  Godfrey L. Smith,et al.  Negative Inotropy of the Gastric Proton Pump Inhibitor Pantoprazole in Myocardium From Humans and Rabbits: Evaluation of Mechanisms , 2007, Circulation.

[4]  ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). , 2006 .

[5]  P. Coumel Atrial fibrillation: one more sporting inconvenience? , 2002, European heart journal.

[6]  D. Swanson,et al.  Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism. , 2006, Medical Hypotheses.

[7]  E. Yazaki,et al.  The role of gastrointestinal endoscopy in long-distance runners with gastrointestinal symptoms , 2001, European journal of gastroenterology & hepatology.

[8]  J. Brugada,et al.  Long-lasting sport practice and lone atrial fibrillation. , 2002, European heart journal.

[9]  M. Mędraś,et al.  Gastroesophageal Reflux Disease and Physical Activity , 2006, Sports medicine.

[10]  D. Wyse Anticoagulation in atrial fibrillation: a contemporary viewpoint. , 2007, Heart rhythm.

[11]  Massimo Santini,et al.  Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. , 2005, Journal of the American College of Cardiology.

[12]  D. Johnson,et al.  Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. , 2004, Gastroenterology.

[13]  J. Finsterer,et al.  Treatment of esophagitis/vagitis-induced paroxysmal atrial fibrillation by proton-pump inhibitors , 2003, Journal of Gastroenterology.

[14]  J. Finsterer,et al.  Reflux Esophagitis in the Pathogenesis of Paroxysmal Atrial Fibrillation: Results of a Pilot Study , 2003, Southern medical journal.

[15]  A. Matalas,et al.  Proton pump inhibition prevents gastrointestinal bleeding in ultramarathon runners: a randomised, double blinded, placebo controlled study , 2006, British Journal of Sports Medicine.

[16]  Neil R. Smalheiser,et al.  Ranking indirect connections in literature-based discovery: The role of medical subject headings , 2006, J. Assoc. Inf. Sci. Technol..

[17]  P. Chambers Lone atrial fibrillation: Pathologic or not? , 2007, Medical hypotheses.

[18]  Peng-Sheng Chen,et al.  Autonomic nerve activity and atrial fibrillation. , 2007, Heart rhythm.

[19]  R. Page,et al.  Asymptomatic atrial fibrillation. , 2005, Progress in cardiovascular diseases.

[20]  G. P. van Berge Henegouwen,et al.  The effect of omeprazole on gastro‐oesophageal reflux and symptoms during strenuous exercise , 1999, Alimentary pharmacology & therapeutics.

[21]  K. Odashiro,et al.  A Case of Paroxysmal Atrial Fibrillation Improved after the Administration of Proton Pump Inhibitor for Associated Reflux Esophagitis , 2007 .

[22]  T. Adrian,et al.  Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes , 1993, Digestive Diseases and Sciences.

[23]  Laura K. Bianchi,et al.  Esophagogastric Junction Morphology Predicts Susceptibility to Exercise-Induced Reflux , 2004, American Journal of Gastroenterology.

[24]  Keishi Kubo,et al.  Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease , 2003, Journal of cardiovascular electrophysiology.

[25]  P Coumel,et al.  Paroxysmal atrial fibrillation: a disorder of autonomic tone? , 1994, European heart journal.

[26]  J. Moeller,et al.  Gastroesophageal reflux in athletes , 2004, Current sports medicine reports.

[27]  G. Triadafilopoulos,et al.  Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. , 2006, Journal of clinical gastroenterology.

[28]  P. Friedman,et al.  Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial. , 2003, Cardiac electrophysiology review.

[29]  D. Castell,et al.  Gastroesophageal reflux in runners. Characteristics and treatment. , 1990, Annals of internal medicine.